Brief: AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
30/04/2025 12:17
April 30 (Reuters) - AC Immune SA ACIU.O: AC IMMUNE Q1 OPERATING EXPENSES CHF -20.36 MILLION AC IMMUNE Q1 EPS CHF -0.19 AC IMMUNE Q1 PRETAX PROFIT CHF -19.029 MILLION AC IMMUNE Q1 NET INCOME CHF -19.029 MILLION AC IMMUNE Q1 OPERATING INCOME CHF -19.37 MILLION Source text: ID:nGNX9VYnXH Further company coverage: ACIU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture